: Gold futures post first monthly decline since October
Gold futures climbed on Tuesday, but registered their first monthly loss in four months. Market expectations reflect a Federal Reserve reaching a 5.25% to 5.5%...
: Arconic stock soars after WSJ report of buyout talks with Apollo Global Management
Shares of Arconic Corp. ARNC rocketed 21.6% toward a 5 1/2-month high in afternoon trading Tuesday, after The Wall Street Journal reported that private-equity firm...
: Luminar Technologies stock rallies after deal news, insurance program
Shares of Luminar Technologies Inc. LAZR rose nearly 3% in midday trading Tuesday after the lidar company unveiled a slew of initiatives during its investor...
: Paramount stock falls after WSJ reports it turned down more than $3 billion bid to buy Showtime
Shares of Paramount Global PARA dropped 2.7% in afternoon trading, after The Wall Street Journal reported that the media and entertainment company had turned down...
: Bed Bath & Beyond stock plunges more than 50% in February, the second-worst monthly performance in its history
Shares of Bed Bath & Beyond Inc. BBBY shed 5.7% in afternoon trading Tuesday, putting them on track to suffer the biggest monthly decline in...
: Oil futures rally for the session, fall for the month
U.S. benchmark crude-oil prices climbed on Tuesday, but marked a fourth monthly loss in a row. “Oil prices have fallen for the month due to...
: S&P 500, Dow trade lower in final hour Tuesday, putting stocks on pace for February losses
U.S. stocks were trading mostly lower Tuesday afternoon, with a focus on inflation that’s been hard to tame reigniting concerns on Wall Street about the...
: U.S. stocks close lower, S&P 500 ends February with biggest monthly loss since December
U.S. stocks closed lower Tuesday, with the S&P 500 finishing February with the worst monthly performance since December amid heightened worries over sticky inflation. The...
: Novavax stock sheds a quarter of its value after hours following revenue miss
Novavax Inc. NVAX shares shares sank in the extended session Tuesday after the biotech drug maker posted a wider-than-expected loss and reorganized with the appointment...